TY - JOUR
T1 - Characteristics at the time of oxygen initiation associated with its adherence
T2 - Findings from the COPD Long-term Oxygen Treatment Trial
AU - for the LOTT Research Group
AU - Moy, Marilyn L.
AU - Harrington, Kathleen F.
AU - Sternberg, Alice L.
AU - Krishnan, Jerry A.
AU - Albert, Richard K.
AU - Au, David H.
AU - Casaburi, Richard
AU - Criner, Gerard J.
AU - Diaz, Philip
AU - Kanner, Richard E.
AU - Panos, Ralph J.
AU - Stibolt, Thomas
AU - Stoller, James K.
AU - Tonascia, James
AU - Yusen, Roger D.
AU - Tan, Ai Yui M.
AU - Fuhlbrigge, Anne L.
N1 - Funding Information:
Dr. Fuhlbrigge has received grant support from the NHBLI, AHRQ and PCORI related to asthma and COPD studies. She also has received personal fees from GSK, AstraZeneca and Icon Medical Imaging for consulting on investigations in asthma and COPD.
Funding Information:
The Long-term Oxygen Treatment Trial (LOTT) was supported through federal funding from the National Heart, Lung, and Blood Institute, National Institutes of Health, Department of Health and Human Services [contracts HHSN268200736183C , HHSN268200736184C , HHSN268200736185C , HHSN268200736186C , HHSN268200736187C , HHSN268200736188C , HHSN268200736189C , HHSN268200736190C , HHSN268200736191C , HHSN268200736192C , HHSN268200736193C , HHSN268200736194C , HHSN268200736195C , HHSN268200736196C , HHSN268200736197C , Y1-HR-7019-01 , and Y1-HR-8076-01 ] in cooperation with the Centers for Medicare and Medicaid Services, Department of Health and Human Services.
Funding Information:
Ms. Sternberg and Dr Tonascia report grants from NIH/NHLBI during the conduct of the study. Dr. Tan reports grants from National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) institutional training grant during the conduct of the study. Dr. Harrington reports grants from NHLBI, grants from NIDA, grants from HRSA during the conduct of the study.
Publisher Copyright:
© 2019 Elsevier Ltd
PY - 2019/3
Y1 - 2019/3
N2 - Rationale: Characteristics associated with adherence to long-term oxygen therapy (LTOT) in COPD remain unclear. Objectives: To identify patient characteristics at the time of oxygen initiation associated with its adherence. Methods: We conducted a secondary analysis of data from 359 COPD participants assigned to oxygen in the Long-term Oxygen Treatment Trial. Participants were prescribed continuous (n = 214) or intermittent (n = 145) oxygen based on desaturation patterns at study entry. At the time of initial prescription, participants rated their perceived readiness, confidence, and importance to use oxygen on a 0–10 scale (0 = not at all, 10 = very much). During follow-up, they self-reported average hours per day of use (adherence). Adherence was averaged over short-term (0–30 days), medium-term (months 9–12), and long-term (month 13 to last follow-up) intervals. Multivariable logistic regression models explored characteristics associated with high adherence (≥16 h/day [continuous] or ≥8 h/day [intermittent]) during each time interval. Results: Participant readiness, confidence, and importance at the time of oxygen initiation were associated with high short- and medium-term adherence. For each unit increase in baseline readiness, the odds of high short-term adherence increased by 21% (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.05–1.40) and 94% (OR 1.94, 95% CI 1.45–2.59) in the continuous and intermittent groups, respectively. In both groups, high adherence in the medium-term was associated with high adherence in the long-term (continuous, OR 12.49, 95% CI 4.90–31.79; intermittent, OR 38.08, 95% CI 6.96–208.20). Conclusions: Readiness, confidence, and importance to use LTOT at initiation, and early high adherence, are significantly associated with long-term oxygen adherence.
AB - Rationale: Characteristics associated with adherence to long-term oxygen therapy (LTOT) in COPD remain unclear. Objectives: To identify patient characteristics at the time of oxygen initiation associated with its adherence. Methods: We conducted a secondary analysis of data from 359 COPD participants assigned to oxygen in the Long-term Oxygen Treatment Trial. Participants were prescribed continuous (n = 214) or intermittent (n = 145) oxygen based on desaturation patterns at study entry. At the time of initial prescription, participants rated their perceived readiness, confidence, and importance to use oxygen on a 0–10 scale (0 = not at all, 10 = very much). During follow-up, they self-reported average hours per day of use (adherence). Adherence was averaged over short-term (0–30 days), medium-term (months 9–12), and long-term (month 13 to last follow-up) intervals. Multivariable logistic regression models explored characteristics associated with high adherence (≥16 h/day [continuous] or ≥8 h/day [intermittent]) during each time interval. Results: Participant readiness, confidence, and importance at the time of oxygen initiation were associated with high short- and medium-term adherence. For each unit increase in baseline readiness, the odds of high short-term adherence increased by 21% (odds ratio [OR] 1.21, 95% confidence interval [CI] 1.05–1.40) and 94% (OR 1.94, 95% CI 1.45–2.59) in the continuous and intermittent groups, respectively. In both groups, high adherence in the medium-term was associated with high adherence in the long-term (continuous, OR 12.49, 95% CI 4.90–31.79; intermittent, OR 38.08, 95% CI 6.96–208.20). Conclusions: Readiness, confidence, and importance to use LTOT at initiation, and early high adherence, are significantly associated with long-term oxygen adherence.
KW - Adherence
KW - COPD
KW - Confidence
KW - LTOT
KW - Readiness
KW - Self-efficacy
UR - http://www.scopus.com/inward/record.url?scp=85061801186&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85061801186&partnerID=8YFLogxK
U2 - 10.1016/j.rmed.2019.02.004
DO - 10.1016/j.rmed.2019.02.004
M3 - Article
C2 - 30803886
AN - SCOPUS:85061801186
SN - 0954-6111
VL - 149
SP - 52
EP - 58
JO - British Journal of Tuberculosis and Diseases of the Chest
JF - British Journal of Tuberculosis and Diseases of the Chest
ER -